Compare IDEXX Laboratories, Inc. (IDXX) vs Peloton Interactive Inc (PTON) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs Peloton Interactive Inc — how do they compare? IDEXX Laboratories, Inc. trades at $551.97 (market cap $44.48B), while Peloton Interactive Inc trades at $6.46 (market cap $2.82B). The key difference: IDEXX Laboratories, Inc. is far larger — about 15.8× Peloton Interactive Inc's market cap, and Peloton Interactive Inc is trading nearer its 52-week high, IDEXX Laboratories, Inc. nearer its low. Which is the better fit depends on your goals.
| IDXX | PTON | |
|---|---|---|
Market Cap | $44.48B | $2.82B |
Sector | Health | Consumer Cyclical |
52-Week High | $766.68 | $9.00 |
52-Week Low | $520.87 | $3.71 |
Enterprise Value | $45.38B | $3.42B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDXX trades at $563.79, down 0.64% today but maintains strong fundamental momentum with consistent earnings beats and robust profitability. The stock shows bullish technical signals with support at $563 and resistance at $572, while valuation metrics remain elevated. Recent Q1 2026 results exceeded expectations with EPS of $3.47 versus $3.41 estimates, supporting the company's leadership in veterinary diagnostics.
Outlook remains positive given strong analyst support (59% buy ratings) and innovation pipeline, though premium valuations and competitive pressures present risks. Revenue growth trajectory and expanding margins provide fundamental support for continued upside potential in the pet healthcare sector.
Peloton (PTON) trades at $6.545, up 6.94% today, showing stabilization after years of decline. The company achieved positive operating cash flow of $333M in 2025 and is projected to return to net profitability in 2026. Technical indicators are bullish on moving averages, while fundamentals reveal high debt levels but improving margins. Recent news highlights leadership changes and inclusion in the S&P SmallCap 600 index as potential catalysts.
Outlook remains cautious but improving; PTON offers turnaround potential with cost controls driving cash flow, but risks include persistent revenue declines and substantial long-term debt of $1.49B. Analyst consensus is mixed with a $7.50 price target, suggesting modest upside if execution continues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About Peloton Interactive Inc
Peloton Interactive Inc operates an interactive fitness platform. It operates its business in two reportable segments: Connected Fitness Products and Subscription. Connected Fitness Product revenue consists of sales of bike and tread and related accessories, associated fees for delivery and installation, and extended warranty agreements. Subscription revenue consists of revenue generated from monthly Connected Fitness Subscription and Digital Subscription. The company generates the majority of the revenue from the sale of Connected Fitness Products.
Read more on PTON →
